We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Premaitha | LSE:NIPT | London | Ordinary Share | GB00BN31ZD89 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 9.10 | 9.00 | 9.20 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
17/5/2016 17:32 | Relentless selling and Uncertainty is killing the share price Setting lower lows | kaka47 | |
17/5/2016 14:32 | one area where that would not always apply is any contract tender where both we and Illumina bid. They usually know other bidders or can find out and are often informed, so in some cases withholding these names/details from the RNS will be meaningless as Illumina will know the outcome and link it to a timely RNS anyway. EDIT - nice one Ngen ;-) bankruptcy favoured the brave last time, so hope we get this one right as somewhat similar aspects with delivering shareholder value, missed expectations and hiccups so far. | twix386 | |
17/5/2016 14:18 | Risking the wrath of Twix for posting :-)) think we should be patient - wait for the overhang to clear and we should motor upwards. Sadly, looks like not all stock picked up by long term holders. Nonetheless, story is good and time to accummulate for the brave ones. Fortune favours the....... | ngen yap | |
17/5/2016 12:32 | I would be amazed if they are not obliged to report anything that could affect the share price via RNS including contracts.. | blackss | |
17/5/2016 11:21 | captain, makes sense to me. snippet from lse c/o flipper shows progress is being made..possibly more than we think! also now in 23/24 countries...so looking good, despite the share price St George's Safe Test, which is based on the IONA Test is available in 10 hospitals in the Southwest Thames region as confirmed directly. So despite the biotheical concerns the NHS implementation seems still to be progressing in stealth mode and the SAFE Test has more coverage over 10 hospitals than some alternative NIPT providers. These 10 hospitals do not include private clinics (Alexander House Wimbledon, Ultrasound Diagnostic Services etc.) nor includes hospitals outside the Southwest Thames region (Leeds General Infirmary, St. James University Hospital etc.) There are also two large private clinics in London which will start offering the Safe Test by end of May. With 10+ I believe the coverage of the Safe Test is more widespread within the NHS than others though Birmingham Hospital, Central Manchester University's St Mary's Hospital, Great Ormond Street Hospital, Portland Hospital have other NIPT tests. More significantly though for me is that the NHS advocate for NIPT implementation is Professor Basky of St George and the Safe Test. Between now and when a Health Statement is released on the wider NHS implementation there has been a doubling of capacity at St George to process blood samples from other NHS hospitals and private clinics. | hjb1 | |
17/5/2016 11:02 | Due to the ongoing court case...They won't announce any small contracts and won't name any companies when larger contracts are signed | captain_kurt | |
17/5/2016 10:37 | ".....heading towards 5p" Any supporting statement to go with that or just pie in the sky nonsense? | cl2201 | |
17/5/2016 10:33 | More selling heading towards 5p | kaka47 | |
16/5/2016 20:55 | Selling/shorting whatever you call it Never ending | kaka47 | |
16/5/2016 13:31 | It's been a while....hopefully they'll have a meaningful contract, or a flurry of smaller ones in the near future. | cl2201 | |
16/5/2016 13:28 | Some meaningful contracts from Premaitha would be good !! | blackss | |
16/5/2016 13:13 | "Premaitha alleges that Illumina's actions raise serious anticompetitive issues. The Court ordered that Illumina has until 28 May 2016 to present any arguments as to why Premaitha's application to include the antitrust defence and counterclaim should not be accepted." 13 days for Illumina to come up with a meaningful argument. Let's see what they have to say. | cl2201 | |
13/5/2016 10:56 | Treading water still, such a shame. | timojelly | |
11/5/2016 16:43 | There should be a main video presentation from the UK Investor Show appearing on share price in the coming days. Not sure if it was Adam Reynolds or SL but either way looking forward to what they had to say. | cl2201 | |
09/5/2016 05:47 | Would the world be a better place without people like my daughter? via It must be close. Decision time. | timojelly | |
08/5/2016 18:12 | When you mention that a director sold shares at 6.5p, are you referring to Charles Roberts (due to his position in Loxbridge)? If so, can you be sure he had any say in the sale of Loxbridge's shares as it seems to have been orchestrated by Rupert Lywood. | cl2201 | |
08/5/2016 16:56 | All this makes it look like i am all doom and gloom but that is not the case and i continue to hold and will add nearer the court date i expect. It just makes me cross when my investments are devalued by flipping which is basically just cash for the boys, sanctioned by the company who don't put a tie in clause on discounted shares. Has anyone here been offered shares at 6.5p ? of course not, wonder why ? | blackss | |
08/5/2016 16:39 | No one is setting themselves up as an authoritative figure but the basics are a director just sold at 6.5p, i'm sure if the market or other directors would have given him 7.5p he would have taken it. The market has NIPT at a premium to 6.5p as its trying to make a market but the reality is if you try and sell a large number or lots of people try and sell a small number they are paying , or expect the privce to drop too,6.5p. You can , like TW , dress it up how you like but the figures are there for all to see and directors selling at a huge discount to the MM's share price does not exactly encourage larger holders. | blackss | |
08/5/2016 16:02 | I do wish some people wanting to set themselves up as authoritative figure(s) would get the basics correct in the first instance. NIPT do NOT value themselves at 6.5p. Last I checked, ONE director sold his entire holding, the last tranche at 6.5p. Unless I am missing something (please feel free to correct me), the remaining directors held their shares. One man/woman may well be very instrumental to the company, but he/she is not the company. You may feel tempted to suggest the market values NIPT at 6.5p, BUT that may be in the future, subject to flippers booking easy money, thanks to NIPT nomad not doing their job. That is another discussion, perhaps. As yet, the market has NIPT at a premium to the 6.5p....for now at any rate. | elrico | |
08/5/2016 14:34 | it might not have been just their decision now others are involved. | hjb1 | |
08/5/2016 13:55 | Its always a possibility but there would be little point in them pulling out till the last minute now Prem have decided to let it run for another year at least. ( huge mistake prem ?) | blackss | |
08/5/2016 12:47 | I think Illumina will pull out. Looking like a basket case busted flush stateside. Shareholders not too happy. | timojelly | |
08/5/2016 12:28 | Short of Illumina pulling out the next key date will be the court hearing in 2017 | blackss |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions